Targeting the Epigenetic Profile of tumor-initiating stem cells

 IDEA for a Cancer  Vaccine:

Can Tissue-Specific, Conserved Epigenetic Signatures, of Tumor Initiating/metastasizing Stem Cells serve as targets for developing an Anti-Cancer Vaccine?